Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

por Girard, N., Ponce Aix, S., Cedres, S., Berghmans, T., Burgers, S., Toffart, A.-C., Popat, S., Janssens, A., Gervais, R., Hochstenbag, M., Silva, M., Burger, I.A., Prosch, H., Stahel, R., Xenophontos, E., Pretzenbaher, Y., Neven, A., Peters, S.
Publicado 2023